RecruitingNCT03758976

Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

SCAN-B-rec: Infrastructure, Technology Platform and Clinical Research Development to Profile and Monitor Metastatic Breast Cancer


Sponsor

Lund University Hospital

Enrollment

2,000 participants

Start Date

Jan 21, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective multicenter observational study to assess molecular drivers of metastatic breast cancer and disease evolution upon therapeutic pressure. The main aim is to develop and validate prognostic, predictive and pathogenic markers in clinically well-characterized population-based material of breast cancer tumors and the corresponding normal tissue.These data will be used to characterize recurrent breast cancer on a molecular level, study tumor evolution, develop biomarkers of response/resistance to targeted therapy in the metastatic setting, enroll patients on targeted treatment clinical studies and to elucidate mechanisms of resistance to therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting blood samples and health data from patients with advanced breast cancer to study cancer genetics and how tumors change over time, which could help improve future treatment strategies. **You may be eligible if...** - You have been diagnosed with advanced breast cancer, including locally advanced disease that cannot be surgically removed, or cancer that has spread to other organs (Stage IV) - You are 18 years or older - Your overall health is reasonably good (ECOG performance status 0–2) - Your cancer is detectable by physical exam or imaging **You may NOT be eligible if...** - Your cancer is early-stage and has not spread - You are in very poor health (ECOG performance status 3 or above) - You have no assessable or measurable disease - You have had imaging more than 6 weeks before enrollment without a recent update Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBiopsies, blood

We will perform targeted exon sequencing on paraffin embedded tissues from metastatic breast cancer


Locations(2)

Lund University Hospital

Lund, Sweden

Lund University Hospital

Lund, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03758976


Related Trials